Search results
Big News for Older Adults: Pneumococcal Vaccine Approved
WebMD· 6 days agoThere’s a new tool to fight invasive pneumococcal disease and pneumococcal pneumonia in adults, as the FDA approved Merck’s new vaccine designed to prevent the disorders. The injectable drug ...
Black patients more likely to experience MACE after ADT for prostate cancer
Medical Xpress· 4 days agoBlack patients are more likely to experience adverse cardiovascular outcomes after systemic androgen...
New Pneumococcal Vaccine Approved
Medscape· 7 days agoThe new vaccine covers eight serotypes not protected by other vaccines already on the market.
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
The Idaho Statesman· 4 days agoA Boise medical expert says you might want to mask up if you visit — or work in — a hospital or clinic, where sick people are most likely to infect others. Infection rates in Idaho have been ...
The secrets of success with Paul Hudson, CEO of Sanofi
Fortune· 5 days agoThe pharma sector has been very profitable for many decades, and its weight in the economy has grown steadily. Hudson moreover joined Sanofi, the leading French pharmaceutical company, just ...
Gateway - The Root
The Root· 7 days agoThis also comes weeks after Mayor Adams said the rule keeping Kyrie Irving, an unvaccinated NBA player for the Brooklyn Nets, from playing in the Barclays Center is unfair but was still...
Gateway - Quartz
Quartz· 6 days agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country even as relations between Washington ...
Three’s a trend. Citi is the latest to bump S&P 500 target, but it sees opportunistic pullbacks...
Market Watch· 7 days agoWall Street is placing more bets on a 5,600 finish for the S&P 500 this year, provided tech behaves.
Sarepta Therapeutics Surges on FDA Approval for Expanded ELEVIDY
Guru Focus· 3 days agoSarepta Therapeutics (SRPT) saw a 36% surge after the FDA approved an expanded indication for ELEVIDYS. The label now includes individuals with Duchenne muscula
Motley Rice adds new consultant
The Post and Courier· 4 days agoThe collaboration was borne of out of Green’s relationship with Motley Rice Partner Linda Singer following the New Jersey native’s transition from Pfizer...
